A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer

Author: Moriwaki Toshikazu   Hirai Shinji   Hironaka Shuichi   Amagai Kenji   Soeda Atsuko   Sato Mikio   Nihei Takeshi   Hirose Mitsuaki   Matsuda Kenji   Ohkawara Atsushi   Yamaguchi Taketo   Ozeki Mitsuharu   Mamiya Takashi   Murashita Tetsuya   Hyodo Ichinosuke  

Publisher: Springer Publishing Company

ISSN: 1436-3291

Source: Gastric Cancer, Vol.17, Iss.2, 2014-04, pp. : 354-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content